Cause by a mutation in the gene coding for Btk.
Resulting in an inability of pre-B cells to make a complete BCR, leading pre-B cell apoptosis
Block B cell development which leads to a lack of antibody production
Disease detect after 6-9 mths
Susceptible to recurrent infection by progenitor bacteria (Pneumocci, Streptococci)
Treatment is routine intravenous Ig therapy